New York · Nonprofit
ROFEH CHOLIM CANCER SOCIETY INC
ROFEH CHOLIM CANCER SOCIETY INC (New York) receives grants from 220 organizations whose IRS filings report $17,376,914 to it, the largest being THE OJC FUND ($6,651,534). 112 of them have funded it in more than one year, and 77% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2024
- $24M
- Funders on record
- 220
- Grants received
- $17M
- Net assets
- $26M
What Rofeh Cholim Cancer Society Inc does
Mission
The organization has been established to help ease the suffering of cancer patients and their families by providing financial subsidies, patient advocacy services, emotional and psychosocial support, assistance in obtaining medical treatment, and education on prevention, detection and treatment of cancer.
As stated on its FY2024 Form 990.
Programs
Rofeh cholim cancer society, rccs, provides an array of services for cancer-stricken patients in need, enabling them access to the best possible medical care. Rccs helps cancer-stricken patients maintain the best health insurance policies by subsidizing the premiums of those unable to pay on their own.
$13,706,201 spentof which $9,841,389 as grants79% of program spendingThe medical referral and support team at rccs (rofeh cholim cancer society) utilizes its extensive knowledge to guide patients through the maze of cancer care options and helps them explore the most appropriate physicians and treatments for their individual diagnosis. Newly diagnosed patients, often confused and afraid, know they can depend on rccs for compassionate support and knowledgeable guidance. With the assistance of rccs' broad network of advisory medical practitioners, rccs representatives provide cancer sufferers with vital information, enabling them to make informed decisions about their medical care as they navigate their journey towards health.
$2,135,791 spentof which $1,533,550 as grants12% of program spendingRccs maintains and administers a "medical subsidy fund" for patients and their families who are in dire financial constraint as a result of cancer and/or related illness.
$1,200,936 spentof which $862,301 as grants7% of program spendingOther program services, not described on the e-filed return.
$251,696 spentof which $180,725 as grants1% of program spending
The 4 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $17,294,624.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $17M to $25M (+47%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2020 4% · 2021 2%. Grants only. Government contracts and fees sit inside program revenue.
121% of ROFEH CHOLIM CANCER SOCIETY INC’s revenue is contributions — more reliant on donations than three-quarters of its peers (80% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2017 → 2023: the base broadened from 31 funders to 69 funders, grant income rose $342k → $3.3M.
29 of 220 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 77% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of ROFEH CHOLIM CANCER SOCIETY INC’s funders (the co-funder graph). Top 30 of 220 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
ROFEH CHOLIM CANCER SOCIETY INC leans on a few funders — its largest provides 38% of grant income and the top three 66%; half comes from just 2 funders.
the vertical line marks half of all grant income — 2 funders to its left
81% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund ROFEH CHOLIM CANCER SOCIETY INC.
Largest funder’s share by year: 2017 35% · 2018 33% · 2019 38% · 2020 37% · 2021 21% · 2022 36% · 2023 42% — growing more concentrated.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
28% of ROFEH CHOLIM CANCER SOCIETY INC's funders are still giving 3 years after their first grant; 51% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
77% of ROFEH CHOLIM CANCER SOCIETY INC's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $3.9M that is directly attributable, 63% of it comes from New York funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $13M arriving through sponsors registered in 16 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
ROFEH CHOLIM CANCER SOCIETY INC has grown faster than half of the 828 philanthropy nonprofits its size.
this organization peer median middle 50% of peers· 828 philanthropy nonprofits $10M–$100M, FY2024
Organizations like ROFEH CHOLIM CANCER SOCIETY INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
70% of spending goes to programs.
Governance
Public support
99%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 6 states
Screen this organization
A dated, signed PDF of the compliance screen for ROFEH CHOLIM CANCER SOCIETY INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds ROFEH CHOLIM CANCER SOCIETY INC?
- ROFEH CHOLIM CANCER SOCIETY INC (New York) receives grants from 220 organizations whose IRS filings report $17,376,914 to it, the largest being THE OJC FUND ($6,651,534). 112 of them have funded it in more than one year, and 77% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does ROFEH CHOLIM CANCER SOCIETY INC have?
- IRS filings report 220 organizations giving $17,376,914 in grants to ROFEH CHOLIM CANCER SOCIETY INC, 112 of which have funded it in more than one year.
- Who is the largest funder of ROFEH CHOLIM CANCER SOCIETY INC?
- THE OJC FUND is the largest funder on record, with $6,651,534 in grants. The full list of funders is on this page.
- How can an organization like ROFEH CHOLIM CANCER SOCIETY INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Rofeh Cholim Cancer Society →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 220 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing